Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Acta Neuropsychiatrica|January 10, 2018
BDNF and NRG1 polymorphisms and temperament in selective serotonin reuptake inhibitor-treated patients with major depressionKadri Andre, Olli Kampman, Merja Viikki, et al.
Neuroreport|November 13, 2004
Neuregulin genotype and medication response in Finnish patients with schizophreniaOlli Kampman, Sami Anttila, Ari Illi, et al.
Psychiatric Genetics|June 5, 2003
NOTCH4 gene promoter polymorphism is associated with the age of onset in schizophreniaSami Anttila, Olli Kampman, Ari Illi, et al.
BMC Psychiatry|April 20, 2013
TPH1 A218C polymorphism and temperament in major depressionKadri Andre, Olli Kampman, Merja Viikki, et al.
Neuroscience Letters|July 12, 2011
Interaction between two HTR2A polymorphisms and gender is associated with treatment response in MDDMerja Viikki, Kaija Huuhka, Esa Leinonen, et al.
Neuroscience Letters|February 22, 2011
P2RX7 polymorphisms Gln460Arg and His155Tyr are not associated with major depressive disorder or remission after SSRI or ECTMerja Viikki, Olli Kampman, Sami Anttila, et al.
Neuroreport|July 11, 2009
5-HTR1A, 5-HTR2A, 5-HTR6, TPH1 and TPH2 polymorphisms and major depressionAri Illi, Eija Setälä-Soikkeli, Merja Viikki, et al.
Neuroscience Letters|April 27, 2010
Vascular endothelial growth factor (VEGF) polymorphism is associated with treatment resistant depressionMerja Viikki, Sami Anttila, Olli Kampman, et al.
Human Psychopharmacology|May 26, 2007
Catechol-O-methyltransferase val108/158met genotype and response to antipsychotic medication in schizophreniaAri Illi, Olli Kampman, Kari Hänninen, et al.
Psychiatry Research|January 15, 2010
Catechol-O-methyltransferase val108/158met genotype, major depressive disorder and response to selective serotonin reuptake inhibitors in major depressive disorderAri Illi, Eija Setälä-Soikkeli, Olli Kampman, et al.
Pageof 3